A Phase 3, Multicenter, Randomized,Double-Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy ofZilucoplan in Subjects with Generalized Myasthenia Gravis

Project: Research project

Project Details

Description

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy of Zilucoplan in Subjects with Generalized Myasthenia Gravis
StatusFinished
Effective start/end date8/1/19 → 7/31/23

Funding

  • RA PHARMACEUTICALS, INC